Searched for
GENNOVA BIOPHARMA
DCGI grants Emergency Use Authorization to Gennova biopharma's Omicron-specific covid boosterThe mRNA-based vaccine was developed by Gennova Biopharmaceuticals using the indigenous platform technology, and supported under the Missio...- Gennova Biopharma seeks DCGI nod for its Omicron boosterGennova has developed an Omicron specific vaccine GEMCOVAC-OM which has been assessed for its safety and immunogenicity when administered a...
- DCGI approves indigenous mRNA Covid jab for emergency use in 18 yrs & aboveAbout 70 lakh doses of the vaccine have already been cleared by the government’s nodal Central Drug Laboratory (CDL) at Kasauli and it is e...
- Gennova Biopharma submits final vaccine trial data to regulatorPune-based Gennova is developing the country's first indigenously developed mRNA vaccine for Covid-19. The subject expert committee under t...
- Gennova Biopharma's COVID-19 vaccine found to be safe in early trialsThe company has been allowed to conduct further studies to test efficacy and other parameters.
- Centre scales down projections for COVID-19 vaccine availabilityThis is less than the 2.16 billion vaccines doses that it had projected for the same time period in a presentation in May. The government h...
- PM asks vaccine companies to ramp up production, assures logistical supportIn May 2020, Modi had directed officials not to differentiate between the public and private sectors and said the government should work as...
- Gennova set to kick off trials for India’s first mRNA vaccineCurrently, the two mRNA vaccines that are under use for Covid-19 are by US drug makers Pfizer and Moderna and have shown to have over 90% e...
- The long and short of how coronavirus vaccine might reach youIndia has an effective polio vaccine delivery network but no experience with mass adult immunisation. Other major challenges include storin...
- PM to hold meeting with floor leaders of all parties on FridayGovernment sources said the PM will chair the meeting, which will begin at 10:30 am, through video conferencing. Senior ministers, includin...
- India looking to be self-reliant in development, production of vaccine against COVID-19While at least five pharmaceutical companies of India are engaged in vaccine development, Serum Institute in Pune has been chosen for mass ...
- After Cyclone Nivar, another storm likely to affect Tamil Nadu: IMD
- 'Delhi Chalo' march: Shabad, Gurbani resonates as farmers' protests enter fifth day on GurpurabAs the farmers' agitation against the new agricultural laws passed by the Narendra Modi government entered its fifth day on Monday, the sou...
- With over 38,000 new COVID-19 cases, India's tally crosses 9.4 million
- PM Narendra Modi looking to ensure seamless coronavirus vaccine deliveryOver half-a-dozen ministries at the Centre and another dozen departments in each state could be involved in this massive vaccine distributi...
- PM Narendra Modi to interact with 3 teams involved in developing Covid vaccine"Tomorrow, on 30th November, 2020, PM @narendramodi will interact, via video conferencing, with three teams that are involved in developing...
- Pandemic: When the going gets tough, innovators step up their gameIndian diagnostic companies had experience in developing test assays for dengue, HIV, TB and H1N1, but with Covid-19 the delay in getting h...
- Gennova Biopharma to start mRNA vaccine trials by the year's end; results likely in March '21The trial results are likely to come in by March 2021, Sanjay Singh, CEO of Pune-based Gennova, told ET. There is a possibility that India ...
- Action between Boehringer Ingelheim and Gennova over stroke medicine moves to courtThe approval of tenectaplase for use in stroke patients has been a point of contention between German drug maker Boehringer Ingelheim and G...
- German giant Boehringer Ingelheim battles India's Gennova Biopharma over stroke treatmentGennova recently secured marketing authorisation of tenectaplase for stroke patients in India, the first such use of the drug anywhere in t...
Load More
